Unlock instant, AI-driven research and patent intelligence for your innovation.

Method of screening for RAGE-amyloid-beta peptide interaction inhibiting materials

An amyloid, RAGE-based technology, used in compound screening, biological testing, biomaterial analysis, etc.

Inactive Publication Date: 2010-09-08
SEOUL NAT UNIV R&DB FOUND
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

No system has been reported that makes it possible to predict how a candidate will function in vivo

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method of screening for RAGE-amyloid-beta peptide interaction inhibiting materials
  • Method of screening for RAGE-amyloid-beta peptide interaction inhibiting materials
  • Method of screening for RAGE-amyloid-beta peptide interaction inhibiting materials

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] Example 1: Using mouse bEND.3 cells to establish a simulated blood-brain barrier system

[0035] 1-1. Selection of cell lines and culture conditions

[0036] The bEND.3 cell line (ATCC CRL2299) was used to construct a simulated blood-brain barrier. Cells that were subcultured early after 5 to 10 passages were used. In order to find culture conditions suitable for the formation of the same tight junctions as in the blood-brain barrier, bEND.3 cells were cultured at different cell densities for different culture times in 24-well Transwell plates (Corning).

[0037] At this point, cells were plated at 1 × 10 per well in a 24-well Transwell plate. 5 , 5×10 4 and 2.5×10 4 Cells were cultured to monitor cell status. When using 1×10 per well 5 When cultured at a density of 300 cells, the cells are too dense to adhere satisfactorily to the bottom of the well, and thus undergo differentiation. Under a light microscope, the cells were observed to be in poor condition. 2...

Embodiment 2

[0063] Example 2: Establishment of mouse bEND.3 cell line overexpressing human RAGE

[0064] The human RAGE gene (SEQ ID NO.5) was introduced into bEND.3 cells via a hygromycin selective vector.

[0065] First, the hygromycin selective vector is pcDNA3.1 / Hygro(+) vector (Invitrogen, Cat no.V870-20), such as Figure 7 shown. The human RAGE gene and the pcDNA3.1 / Hygro(+) vector were digested with two restriction enzymes Xho1 and Kpn1, respectively, followed by ligation to each other in the presence of ligase. The recombinant human RAGE-pcDNA3.1 / Hygro(+) vector thus obtained in Lipofectamin TMLTX reagent (Invitrogen, Cat. No. 15338-100) combined with Plus TM Reagent (Invitrogen, Cat. No. 11514-015) was used to transfect into bEND.3 cells. bEND.3 cells were cultured on plates containing hygromycin (200 μg / ml, AMRESCO, Cat. No. K547). Colonies formed after 2-3 weeks of incubation were picked and cultured in broth to establish a cell line expressing the human RAGE gene. Afte...

Embodiment 3

[0066] Example 3: Determination of the efficiency of antagonism of the transport of amyloid beta peptide using the simulated BBB

[0067] Fluorescent (FITC)-labeled amyloid β-peptide (β-α-amyloid β-protein, aa 1-42, FITC-conjugated / traced, Cat. No.M-2585.1000, Bachem) fluorescence to analyze the inhibitory activity of the candidate on RAGE.

[0068] Human RAGE-overexpressing cell lines were cultured in the upper inserts of Transwell plates at concentrations that formed tight junctions, after which the cells were divided into two groups. One was a negative control, to which only FITC-conjugated amyloid [beta] peptide was added. FITC-conjugated amyloid [beta] peptides and candidates were included in other panels. The fluorescence of the lower chamber was measured at regular intervals of 20 min over 120 min using a spectrofluorometer. The two groups were compared with respect to the mean values ​​of the measurements ( Figure 4 ). Such as Figure 4 As shown, candidates 6,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Provided are a system and a method of screening for RAGE- amyloid beta peptide interaction inhibiting materials using a Transwell plate and a RAGE-expressing cell line.

Description

【Technical field】 [0001] The present invention relates to a system for screening substances inhibiting RAGE-amyloid beta peptide interaction. The present invention also relates to screening methods using the same. 【Background technique】 [0002] Alzheimer's disease (AD) is the most common form of dementia. An estimated 4.5 million people are now living with Alzheimer's disease in the United States alone. It is a neurodegenerative disease diagnosed in more than 10% of people over the age of 65 worldwide. Alzheimer's disease (AD) is a heterogeneous entity that presents as a sporadic and familial disease. Genetic predispositions lead to familial Alzheimer's disease (FAD). The cause of sporadic AD (SAD) is currently unknown. Hereditary Alzheimer's disease is an uncommon form of Alzheimer's disease, accounting for only 5-10% of all Alzheimer's patients. The remaining cases were all sporadic forms. [0003] Research has linked the pathological features of Alzheimer's diseas...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/68
CPCG01N33/502G01N33/6896G01N33/5064G01N2500/00G01N2800/2821G01N33/6845G01N2333/4709G01N2500/02
Inventor 墨仁姬孙成敏
Owner SEOUL NAT UNIV R&DB FOUND